Showing results (11-20 of 303) with videos related to
Sort By:
Pageof 31
Plos One|January 27, 2012
Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumorsElahe A Mostaghel, Keith R Solomon, Kristine Pelton, et al.Cancer|July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancerR Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.Current Urology Reports|August 15, 2018
Improving the Specificity of PSA Screening with Serum and Urine MarkersJames T Kearns, Daniel W LinCurrent Opinion in Urology|June 27, 2017
Prediction models for prostate cancer outcomes: what is the state of the art in 2017?James T Kearns, Daniel W LinThe Canadian Journal of Urology|April 30, 2014
Practical guide to the use of abiraterone in castration resistant prostate cancerElahe A Mostaghel, Daniel W LinClinical Prostate Cancer|March 26, 2004
The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinomaDaniel W Lin, Peter S NelsonCurrent Urology Reports|April 18, 2009
New and novel markers for prostate cancer detectionMichael C Risk, Daniel W LinUrologic Oncology|July 14, 2007
Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United StatesMichael P Porter, Daniel W LinThe Prostate|June 1, 2005
Estrogen effects on tubulin expression and taxane mediated cytotoxicity in prostate cancer cellsR Bruce Montgomery, Michael Bonham, Peter S Nelson, et al.Urologic Oncology|March 28, 2015
Measures of survival benefit in cancer drug development and their limitationsRuth Etzioni, Roman Gulati, Daniel W LinPageof 31